Code | 87410 | ||||||||||
MA number | 46/0140/10-S | ||||||||||
Product Form: | cps mol 30x30 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
Therapeutic Class: | 46 - DERMATOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 19.03.2010 |
PIL: | PIL_Toctino_10 mg_30 mg_01.2024.pdf |
SPC: | SPC_Toctino_10 mg_30 mg_01.2024.pdf |
Safety feature | Yes |
Data update: | 15.02.2018 |